Published in Lab Invest on April 01, 1994
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
Liver regeneration. J Cell Physiol (2007) 6.69
Stem cells and liver regeneration. Gastroenterology (2009) 3.40
The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A (2003) 2.99
TWEAK induces liver progenitor cell proliferation. J Clin Invest (2005) 2.68
Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells (2008) 2.24
Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol (2002) 1.88
Viral hepatocarcinogenesis. Oncogene (2010) 1.73
Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med (2000) 1.68
Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell (2014) 1.61
Activation of stem cells in hepatic diseases. Cell Tissue Res (2007) 1.59
Liver regeneration: alternative epithelial pathways. Int J Biochem Cell Biol (2009) 1.55
Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J Pathol (2003) 1.49
Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol (2000) 1.46
Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta (2007) 1.37
Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro. Am J Pathol (2005) 1.36
Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol (2004) 1.25
Bile ductular damage induced by methylene dianiline inhibits oval cell activation. Am J Pathol (1997) 1.20
Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci U S A (1999) 1.13
Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat. Am J Pathol (2004) 1.12
Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers. Stem Cells (2007) 1.09
Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy. J Clin Invest (2003) 1.09
Fibroblast growth factor enriches the embryonic liver cultures for hepatic progenitors. Am J Pathol (2004) 1.08
HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr (2003) 1.08
Hepatocyte nuclear factor-1 as marker of epithelial phenotype reveals marrow-derived hepatocytes, but not duct cells, after liver injury in mice. Stem Cells (2008) 1.06
Wound healing in the liver with particular reference to stem cells. Philos Trans R Soc Lond B Biol Sci (1998) 1.03
Blast-like cell compartment in carcinogen-induced proliferating bile ductules. Am J Pathol (1996) 1.02
Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. Int J Exp Pathol (2006) 1.01
Coexpression of flt-3 ligand/flt-3 and SCF/c-kit signal transduction system in bile-duct-ligated SI and W mice. Am J Pathol (1997) 0.99
Role of liver progenitors in acute liver injury. Front Physiol (2013) 0.98
Hepatic stem cells. Gut (2000) 0.98
New approaches in the differentiation of human embryonic stem cells and induced pluripotent stem cells toward hepatocytes. Stem Cell Rev (2011) 0.97
Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice. Am J Physiol Gastrointest Liver Physiol (2008) 0.97
Hepatitis C virus and hepatocarcinogenesis. Clin Mol Hepatol (2012) 0.96
Immunohistochemical study of hepatic oval cells in human chronic viral hepatitis. World J Gastroenterol (2001) 0.95
Liver repopulation for the treatment of metabolic diseases. J Inherit Metab Dis (2001) 0.95
Modulation of the gene network connected to interferon-gamma in liver regeneration from oval cells. Am J Pathol (1999) 0.95
Stem cells in liver regeneration and therapy. Cell Tissue Res (2007) 0.95
A population of c-Kit(low)(CD45/TER119)- hepatic cell progenitors of 11-day postcoitus mouse embryo liver reconstitutes cell-depleted liver organoids. J Clin Invest (2003) 0.94
Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells. Int J Biochem Cell Biol (2010) 0.94
Zonal hierarchy of differentiation markers and nestin expression during oval cell mediated rat liver regeneration. Histochem Cell Biol (2006) 0.93
The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells. Curr Top Dev Biol (2014) 0.93
Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes. Am J Pathol (2005) 0.91
Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration. Liver Int (2008) 0.91
Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol (2008) 0.90
Oval cell response in 2-acetylaminofluorene/partial hepatectomy rat is attenuated by short interfering RNA targeted to stromal cell-derived factor-1. Am J Pathol (2006) 0.88
Stem cell factor and its receptor, c-kit, are important for hepatocyte proliferation in wild-type and tumor necrosis factor receptor-1 knockout mice after 70% hepatectomy. Surgery (2008) 0.88
Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1. Am J Pathol (2000) 0.87
Enrichment of a bipotent hepatic progenitor cell from naïve adult liver tissue. Biochem Biophys Res Commun (2007) 0.86
Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease. Gastroenterology (2015) 0.85
Global gene expression profiling reveals a key role of CD44 in hepatic oval-cell reaction after 2-AAF/CCl4 injury in rodents. Histochem Cell Biol (2009) 0.84
Isolation and characterization of liver epithelial cell lines from wild-type and mutant TgN737Rpw mice. Am J Pathol (1997) 0.83
Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol (2013) 0.82
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives. World J Gastroenterol (2015) 0.82
E-cadherin as a reliable cell surface marker for the identification of liver specific stem cells. J Mol Histol (2007) 0.82
Rat liver regeneration following ablation with irreversible electroporation. PeerJ (2016) 0.79
An efficient method of sorting liver stem cells by using immuno-magnetic microbeads. World J Gastroenterol (2006) 0.78
Hepatic progenitors for liver disease: current position. Stem Cells Cloning (2010) 0.78
Effect of vitamin A deficiency on the integrity of hepatocytes after partial hepatectomy. Am J Pathol (1995) 0.77
Molecular regulation of hepatocyte generation in adult animals. Am J Pathol (2002) 0.76
Isolation, characterization and culture of Thy1-positive cells from fetal rat livers. World J Gastroenterol (2006) 0.75
Biology of the adult hepatic progenitor cell: "ghosts in the machine". Prog Mol Biol Transl Sci (2010) 0.75
Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol (1999) 4.98
Basal cell carcinomas in mice overexpressing sonic hedgehog. Science (1997) 3.84
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene (2009) 3.51
Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A (1995) 3.25
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest (2001) 3.02
A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis (1987) 2.98
GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell (1996) 2.86
Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet (1992) 2.63
Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62
Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest (1990) 2.61
Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res (1998) 2.59
In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res (1989) 2.58
A comprehensive map of the porcine genome. Genome Res (1996) 2.52
Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest (1996) 2.42
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene (2012) 2.41
Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest (1999) 2.16
Protein trans-splicing by a split intein encoded in a split DnaE gene of Synechocystis sp. PCC6803. Proc Natl Acad Sci U S A (1998) 2.16
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res (1993) 2.09
Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol (2001) 2.07
Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res (1994) 2.06
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia (2010) 2.01
Selective deficits in the circadian light response in mice lacking PACAP. Am J Physiol Regul Integr Comp Physiol (2004) 2.01
Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol (2011) 1.87
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia (2013) 1.84
Dose-dependent enzyme induction. Clin Pharmacol Ther (1973) 1.84
Expression of hepatic transcription factors during liver development and oval cell differentiation. J Cell Biol (1994) 1.80
Comparative and integrative functional genomics of HCC. Oncogene (2006) 1.75
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol (2000) 1.73
Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem (1999) 1.73
4D embryonic cardiography using gated optical coherence tomography. Opt Express (2006) 1.71
Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol (1994) 1.67
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine (2010) 1.66
Changes in liver blood flow during enzyme induction. Biochem Pharmacol (1971) 1.65
Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest (1992) 1.63
Interindividual differences in rates of drug oxidation in man. Drug Metab Dispos (1974) 1.63
Synthesis and application of modulated polymer gels. Science (1995) 1.62
Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet (1978) 1.59
Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology (2000) 1.59
Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging (2010) 1.59
Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology (1992) 1.58
The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci U S A (1996) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology (1999) 1.50
Endovascular stent-graft treatment for Stanford type A aortic dissection. Eur J Vasc Endovasc Surg (2011) 1.47
Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res (1986) 1.43
Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology (1974) 1.43
Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types. Proc Natl Acad Sci U S A (1983) 1.42
Electromorphic characterization and description of conserved epitopes of the lipooligosaccharides of group A Neisseria meningitidis. Infect Immun (1988) 1.41
Determination of blood flow and endothelial shear stress in human coronary artery in vivo. J Invasive Cardiol (1999) 1.41
Recalculation of the temperature inside capillaries using high buffer concentrations. J Chromatogr A (2001) 1.39
Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem (2000) 1.39
Activation of hepatic stem cell compartment in the rat: role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Differ (1993) 1.38
The sequence of the Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus genome. J Gen Virol (2001) 1.37
Spin state transition in LaCoO3 studied using soft x-ray absorption spectroscopy and magnetic circular dichroism. Phys Rev Lett (2006) 1.36
Partial cloning of rat CD34 cDNA and expression during stem cell-dependent liver regeneration in the adult rat. Hepatology (1997) 1.34
Oval cell differentiation into hepatocytes in the acetylaminofluorene-treated regenerating rat liver. Hepatology (1995) 1.33
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene (2000) 1.33
Precursor-product relationship between oval cells and hepatocytes: comparison between tritiated thymidine and bromodeoxyuridine as tracers. Carcinogenesis (1996) 1.29
Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat. Am J Pathol (1993) 1.28
Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science (1987) 1.28
The Ah locus and the metabolism of chemical carcinogens and other foreign compounds. Adv Cancer Res (1977) 1.27
X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest (2001) 1.27
Microscopic origin of the giant ferroelectric polarization in tetragonal-like BiFeO(3). Phys Rev Lett (2011) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res (1998) 1.23
Cloning, nucleotide sequence, and heterologous expression of the biosynthetic gene cluster for R1128, a non-steroidal estrogen receptor antagonist. Insights into an unusual priming mechanism. J Biol Chem (2000) 1.22
Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Cancer Res (2001) 1.22
Modulation of keratin 14 and alpha-fetoprotein expression during hepatic oval cell proliferation and liver regeneration. J Cell Physiol (1994) 1.22
Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest (1990) 1.22
Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol Cell Biol (2000) 1.21
Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome. Neurobiol Dis (2006) 1.21
Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man. Ann N Y Acad Sci (1971) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
NANOG modulates stemness in human colorectal cancer. Oncogene (2012) 1.19
Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture. Biochem Biophys Res Commun (1996) 1.18
Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J Hepatol (2010) 1.16
Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn J Cancer Res (1990) 1.16
Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Clin Cancer Res (1997) 1.16
Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease. Bioorg Med Chem Lett (1998) 1.16
Hepatic stem cell compartment: activation and lineage commitment. Proc Soc Exp Biol Med (1993) 1.16
In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene. Hepatology (1996) 1.14
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Am J Pathol (1996) 1.14